G. Michailov

1.1k total citations · 1 hit paper
7 papers, 784 citations indexed

About

G. Michailov is a scholar working on Cardiology and Cardiovascular Medicine, Immunology and Infectious Diseases. According to data from OpenAlex, G. Michailov has authored 7 papers receiving a total of 784 indexed citations (citations by other indexed papers that have themselves been cited), including 2 papers in Cardiology and Cardiovascular Medicine, 2 papers in Immunology and 1 paper in Infectious Diseases. Recurrent topics in G. Michailov's work include Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (1 paper), Chronic Lymphocytic Leukemia Research (1 paper) and Medical Practices and Rehabilitation (1 paper). G. Michailov is often cited by papers focused on Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (1 paper), Chronic Lymphocytic Leukemia Research (1 paper) and Medical Practices and Rehabilitation (1 paper). G. Michailov collaborates with scholars based in Germany, United States and Switzerland. G. Michailov's co-authors include Bastian G. Brinkmann, Lorna W. Role, Cary Lai, Michael W. Sereda, Klaus‐Armin Nave, Carmen Birchmeier, Bernhard A. Haug, Markus H. Schwab, Tobias M. Fischer and Anselm K. Gitt and has published in prestigious journals such as Science, Value in Health and Clinical Research in Cardiology.

In The Last Decade

G. Michailov

7 papers receiving 776 citations

Hit Papers

Axonal Neuregulin-1 Regul... 2004 2026 2011 2018 2004 200 400 600

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
G. Michailov Germany 5 491 278 266 87 85 7 784
Ann-Sofie Nilsson Sweden 7 473 1.0× 314 1.1× 442 1.7× 46 0.5× 65 0.8× 8 943
David Pleasure United States 14 370 0.8× 206 0.7× 322 1.2× 68 0.8× 88 1.0× 19 694
Jack T. Wang United States 8 402 0.8× 174 0.6× 353 1.3× 99 1.1× 64 0.8× 8 712
David Trisler United States 15 319 0.6× 266 1.0× 379 1.4× 86 1.0× 44 0.5× 28 885
Konstantin Feinberg United States 9 471 1.0× 236 0.8× 313 1.2× 137 1.6× 101 1.2× 15 737
Erich E. Sirkowski United States 10 449 0.9× 141 0.5× 491 1.8× 104 1.2× 84 1.0× 10 828
Marı́a José Barallobre Spain 15 420 0.9× 289 1.0× 575 2.2× 206 2.4× 42 0.5× 18 1.2k
PF Bartlett Australia 10 435 0.9× 296 1.1× 439 1.7× 55 0.6× 27 0.3× 16 855
Wei‐Ming Duan China 17 276 0.6× 192 0.7× 421 1.6× 54 0.6× 122 1.4× 32 871
Carson J. Cornbrooks United States 13 748 1.5× 395 1.4× 327 1.2× 211 2.4× 102 1.2× 21 1.1k

Countries citing papers authored by G. Michailov

Since Specialization
Citations

This map shows the geographic impact of G. Michailov's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by G. Michailov with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites G. Michailov more than expected).

Fields of papers citing papers by G. Michailov

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by G. Michailov. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by G. Michailov. The network helps show where G. Michailov may publish in the future.

Co-authorship network of co-authors of G. Michailov

This figure shows the co-authorship network connecting the top 25 collaborators of G. Michailov. A scholar is included among the top collaborators of G. Michailov based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with G. Michailov. G. Michailov is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

7 of 7 papers shown
1.
Villa, Guillermo, et al.. (2014). Ldl-C Lowering Efficacy of Evolocumab (Amg 145) Could Reduce Apheresis in Patients At High Risk for Cardiovascular Events in Germany. Value in Health. 17(7). A504–A505. 1 indexed citations
2.
Xu, Weiwei, et al.. (2014). Costs Of Treating Cardiovascular Events In Germany: A Systematic Literature Review. Value in Health. 17(7). A485–A485. 4 indexed citations
3.
Gitt, Anselm K., et al.. (2013). Types and outcomes of cardioversion in patients admitted to hospital for atrial fibrillation: results of the German RHYTHM-AF Study. Clinical Research in Cardiology. 102(10). 713–723. 21 indexed citations
4.
Michailov, G., Glenn Davies, & Karl J. Krobot. (2011). Cost-effectiveness of extended-release niacin/laropiprant added to a stable simvastatin dose in secondary prevention patients not at cholesterol goal in Germany. The European Journal of Health Economics. 13(3). 365–374. 8 indexed citations
5.
Michailov, G., Michael W. Sereda, Bastian G. Brinkmann, et al.. (2004). Axonal Neuregulin-1 Regulates Myelin Sheath Thickness. Science. 304(5671). 700–703. 730 indexed citations breakdown →
6.
Michailov, G., Sylvie Lesage, L Fouillard, et al.. (1996). Autologous bone marrow transplantation is feasible in patients with a prior history of invasive pulmonary aspergillosis.. PubMed. 17(4). 569–72. 19 indexed citations
7.
Michailov, G.. (1957). [Morphological changes in lungs in pneumocystispneumonia].. PubMed. 96(3-4). 146–9. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026